Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective
Drug Development Research · 2026-11 · 87 (7)
DOI: 10.1002/ddr.70389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 22.09.2026. Verfasst von Shuyu Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Protein Kinase Inhibitors, Antineoplastic Agents, Drug Design. Die Arbeit nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, Doctor Foundation of Gannan Normal University.
Abstract (Originalsprache)
BRAF is a cytoplasmic serine‐threonine protein kinase that plays a critical role in the MAPK signaling pathway. BRAF is the only member of the RAF family activated by mutation in human cancers. Many classes of B‐Raf small molecule inhibitors have been identified. In this review, we will highlight typical BRAF inhibitors developed during these decades and provide a reference for the exploration of more potential BRAF inhibitors in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, China.
- Jiangxi Drug Inspection Center, Ganzhou, China.
ORCID-Profile: Jiayi Shen
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
- Doctor Foundation of Gannan Normal University
Zitieren
APA
Jia, S., Lin, J., Wu, J., Xu, H., Zeng, Q., Liu, M., & Shen, J. (2026). Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70389
Vancouver
Jia S, Lin J, Wu J, Xu H, Zeng Q, Liu M, et al. Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70389
BibTeX
@article{Jia2026,
author = {Jia, Shuyu and Lin, Jieman and Wu, Janjun and Xu, Hao and Zeng, Qingwei and Liu, Meipin and Shen, Jiayi},
title = {Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {7},
doi = {10.1002/ddr.70389}
}
EUVIMED